Key result
LAAO provides a non-pharmacologic alternative for stroke prevention in AF patients with OAC contraindications.
Why the study?
Percutaneous left atrial appendage occlusion provides stroke prevention for patients with high risk or contraindications for long-term oral anticoagulation, warranting discussion of practical aspects across available devices.
This review provides a comprehensive overview of the technical and procedural aspects of five major left atrial appendage occlusion devices for stroke prevention in patients with atrial fibrillation.
Closure of the left atrial appendage using percutaneous transcatheter occlusion devices is used for stroke prevention as an alternative for patients with a high risk or contraindications for long-term oral anticoagulation use. Herein, we will discuss the practical aspects of five among the available devices used for interventional left atrial appendage occlusion: Watchman, Amulet, WaveCrest, LAmbre, and Lariat.
No takes yet. Share an insight, caveat, or question.
Gianni et al. (2020) conducted a review in Atrial fibrillation. Left atrial appendage occlusion devices was evaluated. Percutaneous left atrial appendage occlusion devices offer a non-pharmacologic alternative for stroke prevention in atrial fibrillation patients with contraindications to oral anticoagulation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: